当前位置:Public Access >检索试验
Chinese/English
Filter Options

Public title

Verify status

Pay status

Study ailment

Study type

Study phase

       More Options
Reg No. in ChiCTR Public title Ailment Type Phase Registration time Viewed Operation
ChiCTR1900026885

Camrellizumab combined with stereotactic radiotherapy, apatinib mesylate and albumin-conjugated paclitaxel for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with non-sensitive gene mutations: a prospective, single arm, single center, exploratory clinical study

The 900th Hospital of The Joint Logistic Support Force of PLA

NSCLC

Post-market

2019-12-03 1664 Patient list